CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 75-95% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Viemed Healthcare Q3 revenue rises, but slightly misses estimates

By Reuters News


Overview

  • US home-based healthcare provider's Q3 revenue grew 12% yr/yr, slightly missing analyst expectations

  • Company raised low end of full-year revenue guidance and narrowed adjusted EBITDA outlook


Outlook

  • Viemed expects 2026 revenue between $316 mln and $320 mln

  • Company narrows 2026 Adjusted EBITDA outlook to $64 mln-$66 mln

  • Net capital expenditures for 2026 now seen at 8.0%-9.0% of revenue


Result Drivers

  • VENTILATOR PATIENT VOLUME - Co said higher average patient volumes drove growth in ventilator rental revenue

  • PAP AND SLEEP RESUPPLY - Co reported strong growth in PAP therapy and sleep resupply patient counts

  • OPERATING LEVERAGE - Co attributed improved profitability to operating leverage and efficiency gains from earlier investments


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Slight Miss*

$80.67 mln

$80.78 mln (3 Analysts)

Q3 Net Income Attributable to Shareholders

$4.64 mln

Q3 Gross Profit

$46.19 mln

Q3 Income from Operations

$6.96 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Viemed Healthcare Inc is $12.50, about 32.2% above its November 3 closing price of $9.46

  • The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 21 three months ago


Reuters Recommended Reads

  • Nov 3 - Addus HomeCare Q3 adjusted EPS beats estimates; to acquire AccentCare personal care division

  • Nov 3 - Senior care provider InnovAge's Q1 revenue beats as participants increase

  • Nov 3 - AdaptHealth posts Q3 loss due to goodwill impairment charge


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.